These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29422652)

  • 1. RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice.
    Taguchi K; Yamagishi SI; Yokoro M; Ito S; Kodama G; Kaida Y; Nakayama Y; Ando R; Yamada-Obara N; Asanuma K; Matsui T; Higashimoto Y; Brooks CR; Ueda S; Okuda S; Fukami K
    Sci Rep; 2018 Feb; 8(1):2686. PubMed ID: 29422652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
    J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
    Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
    Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-atrial natriuretic peptide (ANP)
    Lu YY; Li SJ; Zhang Z; He S; Guo YT; Hong MN; Shao S; Wang RQ; Zhang J; Wang JG; Gao PJ; Li XD
    Exp Cell Res; 2023 Oct; 431(1):113738. PubMed ID: 37572787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
    Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
    Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.
    Nagase M
    Clin Exp Nephrol; 2010 Aug; 14(4):303-14. PubMed ID: 20533072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.
    Teissier T; Quersin V; Gnemmi V; Daroux M; Howsam M; Delguste F; Lemoine C; Fradin C; Schmidt AM; Cauffiez C; Brousseau T; Glowacki F; Tessier FJ; Boulanger E; Frimat M
    Aging Cell; 2019 Apr; 18(2):e12850. PubMed ID: 30794349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.
    Hu G; Xie D; Chen C; Wang W; Li PL; Ritter JK; Li N
    Am J Hypertens; 2023 Aug; 36(9):509-516. PubMed ID: 37171128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.
    Kawarazaki W; Nagase M; Yoshida S; Takeuchi M; Ishizawa K; Ayuzawa N; Ueda K; Fujita T
    J Am Soc Nephrol; 2012 Jun; 23(6):997-1007. PubMed ID: 22440899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
    Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
    Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway.
    Chen Z; Wu C; Liu Y; Li H; Zhu Y; Huang C; Lin H; Qiao Q; Huang M; Zhu Q; Wang L
    Cell Death Dis; 2020 Aug; 11(8):698. PubMed ID: 32829380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycorticosterone Acetate/Salt-Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure.
    Lother A; Fürst D; Bergemann S; Gilsbach R; Grahammer F; Huber TB; Hilgendorf I; Bode C; Moser M; Hein L
    Hypertension; 2016 Jan; 67(1):130-8. PubMed ID: 26553231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL16 Deficiency Attenuates Renal Injury and Fibrosis in Salt-Sensitive Hypertension.
    Liang H; Ma Z; Peng H; He L; Hu Z; Wang Y
    Sci Rep; 2016 Jun; 6():28715. PubMed ID: 27353044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
    Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
    Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension.
    Wu Y; An C; Jin X; Hu Z; Wang Y
    Sci Rep; 2020 Jan; 10(1):133. PubMed ID: 31924817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
    Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    Gao Y; Liu B; Guo X; Nie J; Zou H; Wen S; Yu W; Liang H
    J Hypertens; 2023 May; 41(5):794-810. PubMed ID: 36883469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.